Caisse Des Depots Et Consignations Harrow Health, Inc. Transaction History
Caisse Des Depots Et Consignations
- $2.39 Trillion
- Q2 2025
A detailed history of Caisse Des Depots Et Consignations transactions in Harrow Health, Inc. stock. As of the latest transaction made, Caisse Des Depots Et Consignations holds 17,522 shares of HROW stock, worth $610,291. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,522
Previous 15,950
9.86%
Holding current value
$610,291
Previous $424 Million
26.13%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding HROW
# of Institutions
179Shares Held
21.6MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$138 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$74.8 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$65.9 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$65.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$33.3 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $943M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...